PVA TePla AG confirmed on Thursday its preliminary results for the fourth quarter and maintained its outlook for fiscal 2026, highlighting a material increase in order intake concentrated in semiconductor-related business.
Quarterly performance
For the fourth quarter, the group recorded sales of €68.9m, a 4% decrease versus the comparable period in 2024. EBITDA dropped by 57% to €6.6m, while EBIT declined 70% to €3.9m.
Revenue movement in the quarter reflected diverging trends across the company's segments. Sales in the semiconductor segment fell by 20% to €41.3m and were partly offset by a 38% increase in the industrial segment, which reached €27.5m.
Order intake and book-to-bill
Order intake surged sharply, rising 110% year-over-year and 25% sequentially to €91.1m. The semiconductor segment led the recovery with a 155% rise in orders, driven by crystal growing equipment and metrology orders. The industrial segment also contributed with a 32.4% increase in orders for the period. The company reported a fourth-quarter book-to-bill ratio of 1.3x.
Margins, balance sheet and investments
The company’s EBITDA margin narrowed to 9.6% from 21.4% in the prior-year fourth quarter. Management said the margin contraction reflected higher operating expenses incurred to support anticipated growth initiatives.
On the balance sheet, PVA TePla reported net debt of €30.5m at quarter end, a reversal from net cash of €6.8m a year earlier.
Guidance and backlog signals
PVA TePla reiterated fiscal 2026 guidance of sales between €255m and €275m and EBITDA of €26m to €31m. For comparison, FactSet consensus stands at revenue of €274m and EBITDA of €34.2m.
Metrology orders year-to-date in the first quarter were reported at €50m, including items with delivery schedules extending into 2027. The company has previously indicated that 2027 revenues are expected to be materially above €300m, suggesting mid-double-digit growth relative to current guidance.
This report focuses on the company’s reported results, order dynamics and confirmed guidance. It does not introduce additional forecasts or assumptions beyond the company’s disclosed figures.